Rezarta Shkreli

Mrs. Rezarta Shkreli

Department of Pharmacy, ALDENT University, Tirana, Tiranë, Albania

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2022 in Journal of Biological Studies
Verified
Journal Article
Open access
PDF file
RSRezarta Shkreli
Rezarta Shkreli
RTRihana Terziu
Rihana Terziu
LMLorena Memushaj
Lorena Memushaj
KDKlodiola Dhamo
Klodiola Dhamo
Essential oils are currently the topic of extensive scientific research, and their potential as active pharmacological chemicals or natural preservatives has attracted the attention of the cosmetic and pharmaceutical industries. Modern cosmetics, with their complex compositions, watery formulations, and direct contact with bacterial skin flora, provide excellent habitat for microbe growth. The use of preservatives is required due to the significant danger of contamination and, as a result, a risk to customers' health. The aim of the study was to formulate and subsequently evaluate the stability of a cosmetic emulsion based on different concentrations of synthetic and natural preservatives. We have performed a cosmetic emulsion base with triethanolamine as an emulsifier. Four samples were prepared using the formulation base and a synthetic preservative, methylparaben, in concentrations 0.2% and 0.3%, and a natural preservative, lemongrass essential oil, in concentrations, 1%, and 2%. The samples were stored for 4 weeks in room conditions. They were evaluated immediately after preparation and for four weeks related to smell, color, odor, consistency, homogeneity, pH, phase separation, viscosity changes and microbial growth. After two weeks, there was a phase separation in two formulations with methylparaben. After four weeks, other formulations were stable in odor, appearance, color, homogeneity. The essential oils didn’t significantly affect the pH values of the formulation, it was in the recommended range. Adding the essential oil affected the viscosity of the formulation base, and the more the concentration of essential oil was more the viscosity of the formulation lowered. The emulsions formulated with lemongrass essential oil had no microbial and fungal growth, so the self-preserving effect was demonstrated. We concluded that cosmetic emulsion entrapped with lemongrass essential oil in a concentration of 1% showed promising stability, physicochemical characteristics and self-preserving effect in room storage conditions.

22 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
NPNatalia Piekuś-Słomka
Natalia Piekuś-Słomka
LMLavinia Patricia Mocan
Lavinia Patricia Mocan
RSRezarta Shkreli
Rezarta Shkreli
CGCristiana Grapă
Cristiana Grapă
KDKinga Denkiewicz
Kinga Denkiewicz
TMTudor Mocan
Tudor Mocan
Statins, which are inhibitors of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase, are an effective pharmacological tool for lowering blood cholesterol levels. This property makes statins one of the most popular drugs used primarily to prevent cardiovascular diseases, where hyperlipidemia is a significant risk factor that increases mortality. Nevertheless, studies conducted mainly in the last decade have shown that statins might prevent and treat liver cancer, one of the leading causes of cancer-related mortality worldwide. This narrative review summarizes the scientific achievements to date regarding the role of statins in liver tumors. Molecular biology tools have revealed that cell growth and proliferation can be inhibited by statins, which further inhibit angiogenesis. Clinical studies, supported by meta-analysis, confirm that statins are highly effective in preventing and treating hepatocellular carcinoma and cholangiocarcinoma. However, this effect may depend on the statin’s type and dose, and more clinical trials are required to evaluate clinical effects. Moreover, their potential hepatotoxicity is a significant caveat for using statins in clinical practice. Nevertheless, this group of drugs, initially developed to prevent cardiovascular diseases, is now a key candidate in hepato-oncology patient management. The description of new drug-statin-like structures, e.g., with low toxicity to liver cells, may bring another clinically significant improvement to current cancer therapies.

1 January 2023 in Journal of Research in Pharmacy
Verified
Journal Article
Open access
PDF file
RSRezarta Shkreli
Rezarta Shkreli
IXIna Xhangoli
Ina Xhangoli